Quick Answer
JUPITER NEUROSCIENCES, INC. reported Net Income of -$2.44 million for fiscal year 2024.
JUPITER NEUROSCIENCES, INC. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Income | -$2.44M +49.0% |
-$4.78M | — |
| Diluted EPS | -$0.08 +55.6% |
-$0.18 | — |
| Total Assets | $6.20M +4074.1% |
$148.6K | — |
| Stockholders Equity | $4.17M +171.9% |
-$5.80M +18.8% |
-$7.14M |
| R&D Expense | $492.7K -48.4% |
$954.8K | — |
| Operating Income | -$3.09M +20.1% |
-$3.87M | — |
| Shares Outstanding | 33.10M +24.8% |
26.53M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$2.29M | -287.1% | -1.6% |
| Diluted EPS | September 30, 2025 | -$0.07 | -250.0% | +0.0% |
| Total Assets | September 30, 2025 | $2.58M | +2911.5% | -35.1% |
| Stockholders Equity | September 30, 2025 | $57.4K | +101.0% | -95.7% |
| R&D Expense | September 30, 2025 | $816.7K | +788.6% | +7.5% |
| Operating Income | September 30, 2025 | -$2.30M | -365.4% | -1.4% |
| Shares Outstanding | September 30, 2025 | 34.29M | +13.8% | -1.5% |
- JUPITER NEUROSCIENCES, INC. reported Net Income of -$2.44 million for fiscal year 2024.
- JUPITER NEUROSCIENCES, INC. showed an increase of +49.0% in Net Income compared to the prior fiscal year.
- JUPITER NEUROSCIENCES, INC. reported Diluted EPS of $0.08 per share (loss) for fiscal year 2024.
- JUPITER NEUROSCIENCES, INC. showed an increase of +55.6% in Diluted EPS compared to the prior fiscal year.
- JUPITER NEUROSCIENCES, INC. reported Total Assets of $6.20 million for fiscal year 2024.
- JUPITER NEUROSCIENCES, INC. showed an increase of +4074.1% in Total Assets compared to the prior fiscal year.
- JUPITER NEUROSCIENCES, INC. reported Stockholders Equity of $4.17 million for fiscal year 2024.
- JUPITER NEUROSCIENCES, INC. showed an increase of +171.9% in Stockholders Equity compared to the prior fiscal year.
- JUPITER NEUROSCIENCES, INC. reported R&D Expense of $492.7 thousand for fiscal year 2024.
- JUPITER NEUROSCIENCES, INC. showed a decrease of -48.4% in R&D Expense compared to the prior fiscal year.
- JUPITER NEUROSCIENCES, INC. reported Operating Income of -$3.09 million for fiscal year 2024.
- JUPITER NEUROSCIENCES, INC. showed an increase of +20.1% in Operating Income compared to the prior fiscal year.
- JUPITER NEUROSCIENCES, INC. reported Shares Outstanding of 33.10 million shares for fiscal year 2024.
- JUPITER NEUROSCIENCES, INC. showed an increase of +24.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: